CCL2 and non-small cell lung carcinoma: Recently, Chen et al. demonstrated that CCL2 inhibition by the upstream silencing of the PIM1 proto-oncogene in NSCLC cells abrogated TAM polarization to an M2-like state and recruitment to the TME.